Cambridge Investment Research Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.15M | Buy |
13,346
+644
| +5% | +$56.5K | ﹤0.01% | 2175 |
|
|
2026
Q1 | $1.15M | Sell |
12,702
-2,414
| -16% | -$222K | ﹤0.01% | 2044 |
|
|
2025
Q4 | $1.36M | Buy |
15,116
+675
| +5% | +$64K | ﹤0.01% | 1867 |
|
|
2025
Q3 | $1.42M | Buy |
14,441
+5,797
| +67% | +$574K | ﹤0.01% | 1774 |
|
|
2025
Q2 | $788K | Sell |
8,644
-899
| -9% | -$86.9K | ﹤0.01% | 2143 |
|
|
2025
Q1 | $1.08M | Sell |
9,543
-1,090
| -10% | -$117K | ﹤0.01% | 1803 |
|
|
2024
Q4 | $1.12M | Buy |
10,633
+766
| +8% | +$82.2K | ﹤0.01% | 1776 |
|
|
2024
Q3 | $1.06M | Sell |
9,867
-258
| -3% | -$28.2K | ﹤0.01% | 1815 |
|
|
2024
Q2 | $1.1M | Sell |
10,125
-837
| -8% | -$98.7K | ﹤0.01% | 1703 |
|
|
2024
Q1 | $1.45M | Buy |
10,962
+10
| +0.1% | +$1.25K | 0.01% | 1472 |
|
|
2023
Q4 | $1.33M | Sell |
10,952
-1,738
| -14% | -$194K | 0.01% | 1462 |
|
|
2023
Q3 | $1.42M | Sell |
12,690
-570
| -4% | -$72.4K | 0.01% | 1352 |
|
|
2023
Q2 | $1.93M | Buy |
13,260
+654
| +5% | +$88.9K | 0.01% | 1194 |
|
|
2023
Q1 | $1.63M | Sell |
12,606
-1,001
| -7% | -$126K | 0.01% | 1251 |
|
|
2022
Q4 | $1.74M | Buy |
13,607
+1,547
| +13% | +$180K | 0.01% | 1165 |
|
|
2022
Q3 | $1.26M | Buy |
12,060
+635
| +6% | +$69.7K | 0.01% | 1326 |
|
|
2022
Q2 | $1.2M | Buy |
11,425
+97
| +0.9% | +$11.5K | 0.01% | 1344 |
|
|
2022
Q1 | $1.45M | Sell |
11,328
-1,845
| -14% | -$222K | 0.01% | 1334 |
|
|
2021
Q4 | $1.63M | Buy |
13,173
+2,053
| +18% | +$269K | 0.01% | 1267 |
|
|
2021
Q3 | $1.58M | Sell |
11,120
-141
| -1% | -$20.7K | 0.01% | 1229 |
|
|
2021
Q2 | $1.76M | Sell |
11,261
-309
| -3% | -$50.1K | 0.01% | 1188 |
|
|
2021
Q1 | $1.8M | Buy |
11,570
+236
| +2% | +$36.6K | 0.01% | 1068 |
|
|
2020
Q4 | $1.7M | Sell |
11,334
-3,091
| -21% | -$437K | 0.01% | 1013 |
|
|
2020
Q3 | $1.91M | Buy |
14,425
+540
| +4% | +$70.5K | 0.01% | 831 |
|
|
2020
Q2 | $1.61M | Buy |
13,885
+3,203
| +30% | +$369K | 0.01% | 869 |
|
|
2020
Q1 | $1.05M | Sell |
10,682
-259
| -2% | -$34K | 0.01% | 947 |
|
|
2019
Q4 | $1.59M | Buy |
10,941
+840
| +8% | +$116K | 0.01% | 899 |
|
|
2019
Q3 | $1.35M | Buy |
10,101
+511
| +5% | +$66K | 0.01% | 921 |
|
|
2019
Q2 | $1.1M | Sell |
9,590
-508
| -5% | -$59.5K | 0.01% | 980 |
|
|
2019
Q1 | $1.25M | Sell |
10,098
-1,204
| -11% | -$137K | 0.01% | 922 |
|
|
2018
Q4 | $1.14M | Sell |
11,302
-994
| -8% | -$112K | 0.01% | 863 |
|
|
2018
Q3 | $1.57M | Buy |
12,296
+3,208
| +35% | +$381K | 0.02% | 782 |
|
|
2018
Q2 | $983K | Buy |
9,088
+249
| +3% | +$27.1K | 0.01% | 992 |
|
|
2018
Q1 | $936K | Sell |
8,839
-424
| -5% | -$49.2K | 0.01% | 970 |
|
|
2017
Q4 | $1.08M | Sell |
9,263
-4,558
| -33% | -$515K | 0.01% | 860 |
|
|
2017
Q3 | $1.57M | Sell |
13,821
-241
| -2% | -$27.8K | 0.02% | 623 |
|
|
2017
Q2 | $1.75M | Sell |
14,062
-861
| -6% | -$102K | 0.03% | 572 |
|
|
2017
Q1 | $1.77M | Sell |
14,923
-3,719
| -20% | -$422K | 0.03% | 479 |
|
|
2016
Q4 | $1.87M | Buy |
18,642
+4,460
| +31% | +$478K | 0.04% | 458 |
|
|
2016
Q3 | $1.79M | Buy |
14,182
+1,272
| +10% | +$157K | 0.03% | 461 |
|
|
2016
Q2 | $1.51M | Buy |
12,910
+477
| +4% | +$54K | 0.03% | 449 |
|
|
2016
Q1 | $1.29M | Buy |
12,433
+5,188
| +72% | +$502K | 0.03% | 478 |
|
|
2015
Q4 | $722K | Buy |
7,245
+460
| +7% | +$45K | 0.02% | 682 |
|
|
2015
Q3 | $619K | Sell |
6,785
-241
| -3% | -$24.2K | 0.02% | 663 |
|
|
2015
Q2 | $745K | Sell |
7,026
-50
| -0.7% | -$5.53K | 0.02% | 627 |
|
|
2015
Q1 | $807K | Sell |
7,076
-64
| -0.9% | -$7.3K | 0.02% | 594 |
|
|
2014
Q4 | $786K | Buy |
7,140
+445
| +7% | +$46.9K | 0.02% | 574 |
|
|
2014
Q3 | $654K | Buy |
6,695
+226
| +3% | +$22.2K | 0.02% | 679 |
|
|
2014
Q2 | $652K | Buy |
6,469
+256
| +4% | +$25K | 0.02% | 616 |
|
|
2014
Q1 | $570K | Buy |
6,213
+14
| +0.2% | +$1.29K | 0.02% | 654 |
|
|
2013
Q4 | $561K | Sell |
6,199
-520
| -8% | -$45K | 0.02% | 611 |
|
|
2013
Q3 | $536K | Sell |
6,719
-333
| -5% | -$26.2K | 0.02% | 602 |
|
|
2013
Q2 | $513K | Buy |
+7,052
| New | +$527K | 0.03% | 531 |
|
Other funds holding ZBH
Cambridge Investment Research Advisors's ZBH Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its Zimmer Biomet (ZBH) stake by 5.1% in Q2 2026, buying an estimated $56.5K and bringing the position to 13,346 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2175.
Cambridge Investment Research Advisors first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.93M in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Cambridge Investment Research Advisors held 13,346 shares of Zimmer Biomet worth $1.15M as of Q2 2026.
- Cambridge Investment Research Advisors bought 644 Zimmer Biomet shares in Q2 2026, an estimated $56.5K.
- Zimmer Biomet made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2175 holding.
- Cambridge Investment Research Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- Cambridge Investment Research Advisors's Zimmer Biomet position peaked at $1.93M in Q2 2023.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.